Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patients who received an influenza immunization OR who reported previous receipt of an influenza immunization
DenominatorAll patients aged 6 months and older seen for a visit between October 1 and March 31
ExclusionsDocumentation of medical reason(s) for not receiving influenza immunization (e.g., patient allergy, other medical reasons)
Documentation of patient reason(s) for not receiving influenza immunization (e.g., patient declined, other patient reasons)
Documentation of system reason(s) for not receiving influenza immunization (e.g., vaccine not available, other system reasons)Testing Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationMeasure Selection AttributesNational Quality Strategy PrioritiesHealth and Well-Being
- Risk Adjustment
- Current or planned use(s)Current Use(s)Planned Use
- Most Recent Endorsement ActivityEndorsed Prevention and Population Health Spring Cycle 2022Initial EndorsementNext Planned Maintenance ReviewPrevention and Population Health Spring 2026Endorsement StatusLast Updated
- Steward Organization EmailSteward Organization Copyright
This Physician Performance Measure (Measure) and related data specifications are owned by the National Committee for Quality Assurance (NCQA). NCQA is not responsible for any use of the Measure. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in the Measure. The Measure can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by healthcare providers in connection with their practices) without obtaining approval from NCQA. Commercial use is defined as the sale, licensing, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. All commercial uses or requests for modification must be approved by NCQA and are subject to a license at the discretion of NCQA. The PCPI’s and AMA’s significant past efforts and contributions to the development and updating of the measure are acknowledged. (C) 2012-2020 National Committee for Quality Assurance. All Rights Reserved.
Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. NCQA disclaims all liability for use or accuracy of any third party codes contained in the specifications.
CPT(R) contained in the Measure specifications is copyright 2004-2020 American Medical Association. LOINC(R) copyright 2004-2020 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2020 International Health Terminology Standards Development Organisation. ICD-10 copyright 2020 World Health Organization. All Rights Reserved.